Overview
Education: Masters Degree, Biostatistics. Duke University School of Medicine. 2018
Overview: Lexie graduated from the master’s program in biostatistics at Duke in 2018. Over the past five years, she has collaborated with doctors, residents, fellows, and medical students in the Department of Neurosurgery and Pharmacy. Additionally, she is currently working with a faculty member in Surgery to investigate the impact of environmental factors on certain diseases. Lexie has extensive experience in data management with large databases, including MarketScan, HCUP, and CMS Medicare. She has also worked with EHR data and has experience with data extraction from DEDUCE and CRDM. Her statistical interests include longitudinal analysis, mediation analysis, survival analysis and latent class analysis.
Educational Background
Master of Biostatistics
Duke University (Durham, NC, USA) 2016-2018
Bachelor of Science
Mathematics, Statistics
University of Wisconsin-Madison (Madison, WI, USA) 2013-2016
Shandong University (Shandong, China) 2011-2013
Current Appointments & Affiliations
Recent Publications
Evaluation of Tacrolimus Concentrations and Clinical Outcomes Between Extended and Immediate Release Formulations in Kidney Transplant.
Journal Article J Pharm Pract · December 2024 Objectives: Tacrolimus remains the mainstay of immunosuppression in kidney transplantation. Understanding the relationship between therapeutic tacrolimus levels and outcomes of acute rejection, patient/graft survival, and tolerability are important. The re ... Full text Link to item CiteDisparities in the treatment of movement disorders using deep brain stimulation.
Journal Article J Neurosurg · July 1, 2024 OBJECTIVE: Deep brain stimulation (DBS) is a well-established treatment for Parkinson's disease (PD) and essential tremor (ET). Although the prevalence of PD and ET can vary by sex and race, little is known about the accessibility of neurosurgical treatmen ... Full text Link to item CiteDisparities in Access to Deep Brain Stimulation and Responsive Neurostimulation Approaches to Drug-Resistant Epilepsy.
Journal Article Neuromodulation : journal of the International Neuromodulation Society · June 2024 BackgroundEpilepsy affects 1% to 2% of the global population, and those who are resistant to medical treatment may be candidates for neuromodulation. In select populations, brain stimulation approaches including deep brain stimulation (DBS) and re ... Full text CiteRecent Grants
Addressing Bias from Missing Data in EHR Based Studies of CVD
ResearchBiostatistician II · Awarded by National Institutes of Health · 2018 - 2023Chronic Refractory Low Back Pain (CRLBP)
ResearchBiostatistician II · Awarded by Mainstay Medical Ltd. · 2021 - 2023Nevro HF10 Outcomes Analysis
ResearchBiostatistician II · Awarded by Nevro Corp · 2020 - 2022View All Grants